Diabete/Diabetes - Diabetes melito do tipo 2 na infância e adolescência: revisão da literatura
Esta página já teve 88.991.187 acessos - desde 16 maio de 2003. Média de 26.992 acessos diários
home | entre em contato
 

Diabete/Diabetes

Diabetes melito do tipo 2 na infância e adolescência: revisão da literatura

17/06/2003

 

 

J Pediatr (Rio J) 2003;79(3):201-8: diabetes melito tipo 2, adolescente, epidemiologia.

Objetivo: análise crítica dos estudos sobre a epidemiologia, fisiopatologia, diagnóstico e tratamento do DM2 no jovem.

Métodos: revisão da literatura nos últimos 10 anos, através de pesquisa no banco de dados Medline, utilizando os termos "diabetes do tipo 2 no jovem".

Resultados: a fisiopatologia do DM2 no jovem é semelhante à do adulto, e compreende tanto a resistência à ação da insulina como uma alteração na função da célula beta-pancreática. O antecedente familiar para DM2, a presença de obesidade, a acanthosis nigricans, o peptídeo C de jejum superior a 0,6 ng/ml, a ausência de auto-anticorpos antiilhotas pancreáticas, em combinações variáveis, são pontos importantes para o diagnóstico desse tipo de DM. Cinco a 25% dos jovens com esse tipo de DM podem apresentar cetoacidose no diagnóstico. Nesses pacientes, o tratamento inicial com insulina é possível de ser descontinuado durante a evolução. A aderência à dieta e ao exercício físico são os elementos mais importantes do tratamento destes adolescentes.

Conclusão: como a obesidade nos jovens tem aumentado, tanto em países industrializados como nos países em industrialização, o DM2 no jovem pode ser considerado um problema emergente também na nossa população.

Referências bibliográficas

Título do artigo: "Diabetes melito do tipo 2 na infância e adolescência: revisão da literatura "

1. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997;44(2):307-37.

 

2. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990;12:49-64.

3. Banerj MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. Antibody negative NIDDM in adult black subject with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994;43(6):741-5.

 

4. Alcolado JC, Majid A, Brockington M, Sweeney MG, Morgan R, Rees A, et al. Mitochondrial gene defects in patients with NIDDM. Diabetologia 1994;37(4):372-6.

5. Barrett TG, Bundey SE, MacLeod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-63.

 

6. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type 1 diabetes: analysis of the data on published incidence trends. Diabetologia 1999;42:1395-403.

7. Rosembloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22(2):345-54.

 

8. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15.

9. Glaser N, McFeerly M, Jones, K. Non-insulin dependent diabetes mellitus in childhood. J Invest Med 1995;43:134A.

 

10. Fagot-Campagna A, Pettitt DJ, Engeugau MM, Rios-Burrows N, Geiss LS, Valdez R, et al. Type 2 diabetes among North American children and adolescents. J Pediatr 2000;136:664-72.

11. Pihoker C, Scott CR, Lensing SY, Crandock MM, Smith JM. Non-insulin dependent diabetes mellitus in African American youths of Arkansas. Clin Pediatr 1998;37:97-102.

 

12. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23(3):381-9.

13. Neufeld ND, Raffal LJ, Landon C, Chen Y-DI, Vadheim CM. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998;21:80-6.

 

14. Kitagawa T, Owada M, Urakami T, Tajima N. Epidemiology of type 1 diabetes mellitus (insulin-dependent) and type 2 diabetes mellitus (non-insulin-dependent) in Japanese children. Diabetes Res Clin Pract 1994;24(suppl):S7-13.

15. Kadiki OA, Reddy MR, Marzouk AA. Incidence of insulin-dependent diabetes (IDDM) and non-insulin-dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract 1996;32:165-73.

 

16. Gortmaker SL, Dietz WH, Sobol AM, Weber CA. Increasing pediatric obesity in the United States. Am J Dis Child 1987;141:535-40.

17. Campaigne BN, Morrison JAS, Schumann BC, Falkner F, Lakatos E, Sprecher D, et al. Indexes of obesity and comparisons with previous national survey data in 9- and 10-year old black and white girls. J Pediatr 1994;124:675-80.

 

18. Chinn S, Rona RJ. Prevalence and trends in overweight and obesity in three cross sectional studies of British children, 1974-94. BMJ 2001;322:24-6.

19. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM. The type 2 family. A setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999;153:1063-7.

 

20. Kitagawa T, Owada M, Urakami T, Yamaguchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal proteins and fat. Clin Pediatr 1998;37:111-5.

21. Srinivasan SR, Bao W, Wattigney WA, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study. Metabolism 1996;45(2):235-40.

 

22. Zimmet P, Collins V, Dowse G, Knight L. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:534-41.

23. Boden G. Role of fatty acids in the pathogenesis of insulin-resistance and NIDDM. Diabetes 1997;46:3-10.

 

24. Dean HJ. Diagnostic criteria for non insulin dependent diabetes in youth (NIDDM-Y). Clin Pediatr 1998;37:67-72.

25. Rosenbloom AL, House DV, Winter WE. Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: research priorities and needs. Clin Pediatr 1998;37:143-52.

 

26. Arslanian SA, Suprasongsin C. Differences in the vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr 1996;129:440-3.

27. Eriksson J, Franssila K, Eksrtrand A. Early metabolic defects in people at increased risk for non insulin dependent diabetes mellitus. N Engl J Med 1989;321:337-43.

 

28. Bloch CA, Clemons P, Sperling MA. Puberty decreases insulin sensitivity. J Pediatr 1987;110:481-7.

29. Arslanian SA, Kalhan SC. Correlation between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes 1994;43:908-14.

 

30. Acerini CL, Cheetham TD, Edge JA, Dunger, DB. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age. Diabetologia 2000;43:61-8.

31. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Bennett PH, Knowler WC. Glucose, insulin concentration and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia 1994;37:617-23.

 

32. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996;39:1489-97.

33. Kobayashi K, Amemiya S, Higashida K, Ishihara T. Pathogenic factors of glucose intolerance in obese Japanese adolescents with type 2 diabetes. Metabolism 2000;49:186-91.

 

34. Cesarini PR. Influência do antecedente familiar de diabetes mellitus tipo 1 e tipo 2 sobre o índice de massa corpórea, função de célula beta, sensibilidade à insulina e presença de autoanticorpos anti-GAD e IA2 em crianças e adolescentes [tese de doutorado]. São Paulo: UNIFESP; 2001.

35. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International Survey. BMJ 2000;320:1240-3.

 

36. Rosenbloom A, Joe J, Young R, Winter W. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.

37. Fagot-Camapagna A, Narayan KMV. Type 2 diabetes in children [editorial]. BMJ 2001;322:377-8.

 

38. Phillips DI, Barker DJ, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994;37:150-4.

39. Pettitt D, Aleck K, Baird R, Carraher MJ, Bennett P, Knowler W. Congenital susceptibility to NIDDM. Diabetes 1998;37:622-8.

 

40. Libman I, Silva AA. Type II diabetes mellitus: no longer just adults. Pediatr Ann 1999;28:589-93.

41. Stuart CA, Gilkison R, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr 1998;37:73-80.

 

42. Ehtisham S, Barett TG, Shaw NJ. Type 2 diabetes mellitus in UK children - an emerging problem. Diabet Med 2000;17:867-71.

43. Fajans SS, Bell GI, Polonsky KS. Mechanisms of disease: molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-80.

 

44. Katzeff H, Savage P, Barclay-White B, Nagulesparan, Bennett P. C-peptide measurement in the differentiation of type 1(insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1985;28:264-8.

45. Hother-Nielsen O, Faber O, Sorensen N, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1998;11:531-7.

 

46. Libman I, Pietropaolo M, Trucco M, Dorman J, Porte R, Becker D. Islet cell autoimmunity in white and black children and adolescents with IDDM. Diabetes Care 1998;21:1824-7.

47. Umpierrez G, Woo W, Hagopian W, Isaccs S, Palmer J, Gaur L, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999;22:1517-23.

 

48. Alves LI, Silva MRE, Correia MRS, Fukui RT, Wajchenberg BL, Santos RF, et al. Prevalência de autoanticorpos ICA, IAA, anti-GAD65 e IA2 em familiares de diabéticos do tipo 1. Anais do XXIV Congresso Brasileiro de Endocrinologia e Metabologia. 2000:S43.

49. Jones KL. Non-insulin dependent diabetes in children and adolescents: the therapeutic challenge. Clin Pediatr 1998;37:103-10.

 

50. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393.

51. Jones KL, Silva A, Peterokova VA, Park J-S, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002;25:89-94.

 

52. Knowler W, Narayan K, Hanson R, Nelson R, Bennett P, Tuomilehto J, et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-8.

53. Cook V, Hurley J. Prevention of type 2 diabetes in childhood. Clin Pediatr 1998;37:123-30.

 

54. Hansen JR, Fulop MJ, Hunter MK. Type 2 diabetes mellitus in youth: a growing challenge. Clin Diabetes 2000;18(2):56-61.

 

Monica Gabbay - Endocrinologista Pediatra, Mestre em Pediatria pelo Curso de Pós-graduação em Pediatria da UNIFESP - Escola Paulista de Medicina.

 

 

Paulo R. Cesarini - Doutor em Endocrinologia pelo Curso de Pós-Graduação em Endocrinologia Clínica da UNIFESP - Escola Paulista de Medicina.

  Sergio A. Dib - Professor Adjunto da Disciplina de Endocrinologia e Coordenador do Centro de Diabetes da UNIFESP - Escola Paulista de Medicina.

JPED


IMPORTANTE

  •  Procure o seu médico para diagnosticar doenças, indicar tratamentos e receitar remédios. 
  • As informações disponíveis no site da Dra. Shirley de Campos possuem apenas caráter educativo.
Publicado por: Dra. Shirley de Campos
versão para impressão

Desenvolvido por: Idelco Ltda.
© Copyright 2003 Dra. Shirley de Campos